These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 37154625)
1. The differential crosstalk of the skin-gut microbiome axis as a new emerging actor in systemic sclerosis. Russo E; Bellando-Randone S; Carboni D; Fioretto BS; Romano E; Baldi S; El Aoufy K; Ramazzotti M; Rosa I; Lepri G; Di Gloria L; Pallecchi M; Bruni C; Melchiorre D; Guiducci S; Manetti M; Bartolucci GL; Matucci-Cerinic M; Amedei A Rheumatology (Oxford); 2024 Jan; 63(1):226-234. PubMed ID: 37154625 [TBL] [Abstract][Full Text] [Related]
2. Cross-sectional study using the University of California, Los Angeles, Scleroderma Clinical Trials Consortium Gastrointestinal Tract Instrument 2.0 (UCLA SCTC GIT 2.0) for gastrointestinal disorders of systemic sclerosis. Hisada S; Takeuchi S; Tozawa T; Yamada Y; Ito Y; Kodera M J Dermatol; 2024 Jul; ():. PubMed ID: 38963343 [TBL] [Abstract][Full Text] [Related]
3. Performance of the UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract 2.0 instrument as a clinical decision aid in the routine clinical care of patients with systemic sclerosis. Zampatti N; Garaiman A; Jordan S; Dobrota R; Becker MO; Maurer B; Distler O; Mihai C Arthritis Res Ther; 2021 Apr; 23(1):125. PubMed ID: 33888149 [TBL] [Abstract][Full Text] [Related]
4. Responsiveness of the University of California Los Angeles Scleroderma Clinical Trial Consortium gastrointestinal tract 2.0 (UCLA-SCTC-GIT 2.0)to change in scleroderma patients. Suliman YA; Kafaja S; Alemam M; Shaweesh Y; Tavakoli K; Furst DE J Scleroderma Relat Disord; 2021 Oct; 6(3):236-241. PubMed ID: 35387210 [TBL] [Abstract][Full Text] [Related]
5. Integrative analysis of the gut microbiota and faecal and serum short-chain fatty acids and tryptophan metabolites in patients with cirrhosis and hepatic encephalopathy. Wang Q; Chen C; Zuo S; Cao K; Li H J Transl Med; 2023 Jun; 21(1):395. PubMed ID: 37330571 [TBL] [Abstract][Full Text] [Related]
6. Reliability and validity of the Korean version of the University of California-Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract instrument in patients with systemic sclerosis. Lee TH; Lee JS; Park S; Lee KA; Kim HS Korean J Intern Med; 2021 Nov; 36(6):1504-1514. PubMed ID: 33561335 [TBL] [Abstract][Full Text] [Related]
7. Effect of probiotics on gastrointestinal symptoms and immune parameters in systemic sclerosis: a randomized placebo-controlled trial. Marighela TF; Arismendi MI; Marvulle V; Brunialti MKC; Salomão R; Kayser C Rheumatology (Oxford); 2019 Nov; 58(11):1985-1990. PubMed ID: 31056685 [TBL] [Abstract][Full Text] [Related]
8. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Cutolo M; Pizzorni C; Tuccio M; Burroni A; Craviotto C; Basso M; Seriolo B; Sulli A Rheumatology (Oxford); 2004 Jun; 43(6):719-26. PubMed ID: 15026581 [TBL] [Abstract][Full Text] [Related]
9. High-resolution manometry compared with the University of California, Los Angeles Scleroderma Clinical Trials Consortium GIT 2.0 in Systemic Sclerosis. Abozaid HSM; Imam HMK; Abdelaziz MM; El-Hammady DH; Fathi NA; Furst DE Semin Arthritis Rheum; 2017 Dec; 47(3):403-408. PubMed ID: 28624173 [TBL] [Abstract][Full Text] [Related]
10. Extended autoantibody panel in Turkish patients with early-stage systemic sclerosis: Coexpressions and their influences on clinical phenotypes. Temiz Karadağ D; Komac A; Erez Y; Birlik AM; Sari A; Akdoğan A; Farisogullari B; Kimyon G; Koc E; Arslan D; Karatas A; Koca SS; Kasifoglu N; Yazici A; Hayran KM; Cefle A Immun Inflamm Dis; 2023 Dec; 11(12):e1089. PubMed ID: 38134320 [TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal tract involvement in systemic sclerosis: The roles of diet and the microbiome. Nguyen AD; Andréasson K; McMahan ZH; Bukiri H; Howlett N; Lagishetty V; Lee SM; Jacobs JP; Volkmann ER Semin Arthritis Rheum; 2023 Jun; 60():152185. PubMed ID: 36870237 [TBL] [Abstract][Full Text] [Related]
12. A review and roadmap of the skin, lung and gut microbiota in systemic sclerosis. Teaw S; Hinchcliff M; Cheng M Rheumatology (Oxford); 2021 Dec; 60(12):5498-5508. PubMed ID: 33734316 [TBL] [Abstract][Full Text] [Related]
13. Gut microbiota profile in systemic sclerosis patients with and without clinical evidence of gastrointestinal involvement. Patrone V; Puglisi E; Cardinali M; Schnitzler TS; Svegliati S; Festa A; Gabrielli A; Morelli L Sci Rep; 2017 Nov; 7(1):14874. PubMed ID: 29093509 [TBL] [Abstract][Full Text] [Related]